Align Technology | ALGN - Eigenkapital Und Reserven

Aktienkurs
179.32
Täglich Wechseln
-1.54 -0.85%
Monatlich
-4.64%
Jährlich
5.48%
Q1 Prognose
167.98




Eigenkapital Und Reserven Veränderung Datum
3M USD 4.75B 119M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
CVS Health USD 75.21B 2.29B 2025-12
Danaher USD 52.53B 1.46B 2025-12
Dentsply International USD 1.34B 139M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Henry Schein USD 3.24B 116M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Masimo USD 721.2M 88.8M 2025-12
McKesson USD -1.3B 441M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Solventum Corp USD 5.05B 63M 2025-12
Stryker USD 21.78B 594M 2025-09
Teleflex USD 3.12B 697.09M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Veeva Systems USD 7.21B 174.12M 2025-12
Waters USD 2.56B 230.55M 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12
Zoetis USD 3.33B 2.07B 2025-12